Work

Abstract 5875: Multikinase inhibitor olverembatinib (HQP1351) is efficacious and synergizes with BTK inhibitor acalabrutinib in mantle cell lymphoma (MCL) preclinical models

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-5875

Authors: Bo Peng, Zhiyan Liang, Yan Xiong, Bingxing Wu, Shujie He, Zhou Yu, Guoqin Zhai, Dajun Yang, Yifan Zhai

Institution: Ascentage Pharma Group Inc. (United States)

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7148788574

Cites:

Cited by:

Related to: